US EditionNews in brief: new sites for Avecho CBD trial; Cann Group's R&D tax advance
Summary by Cannabiz
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
News in brief: new sites for Avecho CBD trial; Cann Group's R&D tax advance
Three new sites for Avecho Biotechnology’s low-dose CBD insomnia trial are expected to begin patient recruitment […] The post News in brief: new sites for Avecho CBD trial; Cann Group’s R&D tax advance appeared first on Cannabiz.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
